跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
HIDROCLOROTIAZIDA CINFA 12,5 MG COMPRIMIDOS
Approved
STANDARD
HIDROCLOROTIAZIDA CINFA 12,5 MG COMPRIMIDOS
Laboratorios Cinfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 7, 2025
Approval ID
84a5ef78d239037b
Company
Laboratorios Cinfa S.A.
Type
Standard
Approval Details
Approval Id
84a5ef78d239037b
Drug Cima Aemps Name
HIDROCLOROTIAZIDA CINFA 12,5 MG COMPRIMIDOS
Register Number
90051
Holder Company Name
Laboratorios Cinfa S.A.
Marketing Company Name
Laboratorios Cinfa S.A.
Authorization Date
2025-01-07
Dosage Form
COMPRIMIDO
Dose
12,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
Yes
Company Name
Laboratorios Cinfa S.A.
Active Ingredients
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 7, 2025
Approval ID
84a5ef78d239037b
Type
Standard
Back to CIMA-AEMPS Approvals
HIDROCLOROTIAZIDA CINFA 12,5 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details